TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 73 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $76,000 | +94.9% | 2,026 | +95.0% | 0.00% | – |
| Q2 2023 | $39,000 | +1200.0% | 1,039 | +664.0% | 0.00% | – |
| Q1 2023 | $3,000 | – | 136 | +4433.3% | 0.00% | – |
| Q4 2022 | $0 | – | 3 | +200.0% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 1 | -99.8% | 0.00% | – |
| Q2 2022 | $18,000 | -25.0% | 501 | -8.1% | 0.00% | – |
| Q1 2022 | $24,000 | -7.7% | 545 | +5.4% | 0.00% | – |
| Q4 2021 | $26,000 | -99.0% | 517 | -98.8% | 0.00% | -100.0% |
| Q3 2021 | $2,701,000 | -59.1% | 42,443 | -53.7% | 0.00% | -50.0% |
| Q2 2021 | $6,596,000 | -9.2% | 91,669 | -6.9% | 0.00% | 0.0% |
| Q1 2021 | $7,261,000 | +0.9% | 98,457 | +0.5% | 0.00% | 0.0% |
| Q4 2020 | $7,194,000 | +34.2% | 97,985 | +0.2% | 0.00% | 0.0% |
| Q3 2020 | $5,361,000 | -14.7% | 97,754 | +3.4% | 0.00% | 0.0% |
| Q2 2020 | $6,286,000 | +19.8% | 94,541 | +10.3% | 0.00% | -33.3% |
| Q1 2020 | $5,245,000 | -34.7% | 85,698 | -6.2% | 0.00% | 0.0% |
| Q4 2019 | $8,036,000 | +23.1% | 91,393 | +5.6% | 0.00% | 0.0% |
| Q3 2019 | $6,527,000 | -4.4% | 86,511 | +8.3% | 0.00% | 0.0% |
| Q2 2019 | $6,824,000 | -24.8% | 79,888 | -4.9% | 0.00% | -25.0% |
| Q1 2019 | $9,077,000 | +24.5% | 83,974 | -2.5% | 0.00% | 0.0% |
| Q4 2018 | $7,288,000 | -13.9% | 86,104 | +0.1% | 0.00% | 0.0% |
| Q3 2018 | $8,461,000 | -13.3% | 86,040 | +2.0% | 0.00% | 0.0% |
| Q2 2018 | $9,761,000 | +56.1% | 84,375 | +33.2% | 0.00% | +33.3% |
| Q1 2018 | $6,252,000 | -7.4% | 63,328 | -1.8% | 0.00% | 0.0% |
| Q4 2017 | $6,750,000 | +169.6% | 64,458 | +190.1% | 0.00% | +200.0% |
| Q3 2017 | $2,504,000 | +153.2% | 22,216 | +151.5% | 0.00% | 0.0% |
| Q2 2017 | $989,000 | -91.4% | 8,833 | -91.0% | 0.00% | -83.3% |
| Q1 2017 | $11,508,000 | +10.6% | 98,679 | -0.2% | 0.01% | 0.0% |
| Q4 2016 | $10,407,000 | +1146.3% | 98,859 | +1207.5% | 0.01% | – |
| Q3 2016 | $835,000 | -56.3% | 7,561 | -42.4% | 0.00% | -100.0% |
| Q2 2016 | $1,912,000 | +229.1% | 13,132 | +223.9% | 0.00% | – |
| Q1 2016 | $581,000 | +635.4% | 4,054 | +694.9% | 0.00% | – |
| Q4 2015 | $79,000 | +11.3% | 510 | +2.0% | 0.00% | – |
| Q3 2015 | $71,000 | -1.4% | 500 | 0.0% | 0.00% | – |
| Q2 2015 | $72,000 | 0.0% | 500 | -1.0% | 0.00% | – |
| Q1 2015 | $72,000 | -2.7% | 505 | +1.0% | 0.00% | – |
| Q4 2014 | $74,000 | -19.6% | 500 | -16.7% | 0.00% | – |
| Q3 2014 | $92,000 | +31.4% | 600 | +20.0% | 0.00% | – |
| Q2 2014 | $70,000 | +1650.0% | 500 | +1011.1% | 0.00% | – |
| Q4 2013 | $4,000 | – | 45 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 565,951 | $24,483,000 | 8.44% |
| Murchinson Ltd. | 162,703 | $7,039,000 | 1.34% |
| Eversept Partners, LP | 220,286 | $9,529,572 | 0.73% |
| BRANDES INVESTMENT PARTNERS, LP | 379,322 | $16,410,000 | 0.35% |
| Analyst IMS Investment Management Services Ltd. | 17,657 | $764,000 | 0.07% |
| Claret Asset Management Corp | 7,279 | $315,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 326,427 | $14,086,000 | 0.06% |
| Renaissance Technologies | 678,300 | $29,343,000 | 0.03% |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 191,820 | $8,298,000 | 0.03% |
| ARK Investment Management | 55,566 | $2,404,000 | 0.01% |